Less frequent natalizumab (Tysabri)
Extending infusions of natalizumab (Tysabri) to every eight weeks was just as effective as every four weeks according to a study presented at the American Academy of Neurology (AAN) meeting.
Newswise
Natalizumab (Tysabri) - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news